A PYMNTS Company

US: Justice Department wants more info on Aetna-CVS merger

By  |  February 4, 2018

The Department of Justice (DOJ) is seeking more information, and so will get more time, to review the multibillion-dollar deal between CVS and Aetna.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Federal regulators sent CVS and Aetna the request for additional information about their transaction just before the 30-day waiting period—mandated by the Hart Scott Rodino Act—was set to expire on Friday, February 2, according to a Securities and Exchange Commission (SEC) filing. The move triggers another 30-day waiting period, during which the DOJ will continue to review the deal.

    “CVS Health and Aetna have been cooperating with the DOJ staff since shortly after the announcement of the merger agreement and are continuing to cooperate with the DOJ staff in its review of the transactions contemplated by the merger agreement,” the firms said in their filing with the SEC.

    The DOJ’s request for more information, while not unsurprising for a deal of this size, shows it is carefully scrutinizing CVS’ bid to purchase Aetna. The transaction is valued at US$69 billion, or US$77 billion with the assumption of Aetna’s debt.

    Full Content: CNBC

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.